Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
35
TRST Quote, Financials, Valuation and Earnings
Last price:
$33.59
Seasonality move
:
1.19%
Day range:
$33.08 - $34.30
52-week range:
$25.83 - $38.89
Dividend yield:
4.29%
P/E ratio:
13.43x
P/S ratio:
3.73x
P/B ratio:
0.95x
Volume:
429K
Avg. volume:
98.5K
1-year change:
9.24%
Market cap:
$638.4M
Revenue:
$190.2M
EPS (TTM):
$2.50
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $174.4M | $170.8M | $178.3M | $199.4M | $190.2M | |
| Revenue Growth (YoY) | -2.44% | -2.09% | 4.45% | 11.8% | -4.63% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $50.9M | $49.8M | $53.7M | $51.1M | $57.4M | |
| Other Inc / (Exp) | -- | $1.2M | -- | -- | -- | |
| Operating Expenses | $50.9M | $49.8M | $53.7M | $51.1M | $57.4M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $76.5M | $69.4M | $82.1M | $99.4M | $77.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $18.7M | $17M | $20.6M | $24.2M | $19M | |
| Net Income to Company | $57.8M | $52.5M | $61.5M | $75.2M | $58.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $57.8M | $52.5M | $61.5M | $75.2M | $58.6M | |
| Basic EPS (Cont. Ops) | $2.99 | $2.72 | $3.19 | $3.93 | $3.08 | |
| Diluted EPS (Cont. Ops) | $2.98 | $2.72 | $3.19 | $3.93 | $3.08 | |
| Weighted Average Basic Share | $19.4M | $19.3M | $19.3M | $19.1M | $19M | |
| Weighted Average Diluted Share | $19.4M | $19.3M | $19.3M | $19.1M | $19M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $112.8M | $94.2M | $89.7M | $105.9M | $132M | |
| Revenue (Reported) | $174.4M | $170.8M | $178.3M | $199.4M | $190.2M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $112.8M | $94.2M | $89.7M | $105.9M | $132M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $42.5M | $44.2M | $52.2M | $46.8M | $43.6M | |
| Revenue Growth (YoY) | -2.44% | 3.94% | 18.1% | -10.32% | -6.82% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $11.9M | $13M | $13.4M | $14.1M | $13.6M | |
| Other Inc / (Exp) | -- | -- | -- | -- | $23K | |
| Operating Expenses | $11.9M | $13M | $13.4M | $14.1M | $13.6M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $18.8M | $22.3M | $25.7M | $19.2M | $16.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $4.8M | $5.5M | $6.4M | $4.6M | $4M | |
| Net Income to Company | $14.1M | $16.8M | $19.4M | $14.7M | $12.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $14.1M | $16.8M | $19.4M | $14.7M | $12.9M | |
| Basic EPS (Cont. Ops) | $0.73 | $0.87 | $1.01 | $0.77 | $0.68 | |
| Diluted EPS (Cont. Ops) | $0.73 | $0.87 | $1.01 | $0.77 | $0.68 | |
| Weighted Average Basic Share | $19.3M | $19.2M | $19.1M | $19M | $19M | |
| Weighted Average Diluted Share | $19.3M | $19.3M | $19.1M | $19M | $19M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $24.7M | $24.1M | $27M | $34.6M | $39.3M | |
| Revenue (Reported) | $42.5M | $44.2M | $52.2M | $46.8M | $43.6M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $24.7M | $24.1M | $27M | $34.6M | $39.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $169.9M | $176.8M | $190.3M | $201M | $171.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $49.3M | $53.1M | $50.3M | $57.9M | $54.2M | |
| Other Inc / (Exp) | $1.2M | -- | -- | -- | $1.4M | |
| Operating Expenses | $49.3M | $53.1M | $50.3M | $57.9M | $54.2M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $69.9M | $78.3M | $93.5M | $92.2M | $62.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $17.3M | $19.2M | $23M | $22.5M | $14.8M | |
| Net Income to Company | $52.5M | $59.1M | $70.6M | $69.7M | $47.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $52.5M | $59.1M | $70.6M | $69.7M | $47.4M | |
| Basic EPS (Cont. Ops) | $2.72 | $3.07 | $3.68 | $3.66 | $2.50 | |
| Diluted EPS (Cont. Ops) | $2.72 | $3.06 | $3.68 | $3.66 | $2.50 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $99.9M | $88.4M | $98.6M | $129.4M | $150.6M | |
| Revenue (Reported) | $169.9M | $176.8M | $190.3M | $201M | $171.5M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $99.9M | $88.4M | $98.6M | $129.4M | $150.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $127.5M | $133.5M | $145.4M | $147.1M | $128.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $36.9M | $40.2M | $36.7M | $43.5M | $40.3M | |
| Other Inc / (Exp) | $1.2M | -- | -- | -- | $1.4M | |
| Operating Expenses | $36.9M | $40.2M | $36.7M | $43.5M | $40.3M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $51.6M | $60.5M | $71.9M | $64.7M | $49.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13M | $15.2M | $17.6M | $15.9M | $11.7M | |
| Net Income to Company | $38.6M | $45.3M | $54.3M | $48.8M | $37.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $38.6M | $45.3M | $54.3M | $48.8M | $37.6M | |
| Basic EPS (Cont. Ops) | $2.00 | $2.35 | $2.83 | $2.56 | $1.98 | |
| Diluted EPS (Cont. Ops) | $2.00 | $2.35 | $2.83 | $2.56 | $1.98 | |
| Weighted Average Basic Share | $57.9M | $57.8M | $57.5M | $57.1M | $57.1M | |
| Weighted Average Diluted Share | $57.9M | $57.8M | $57.5M | $57.1M | $57.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $72.4M | $66.6M | $75.5M | $99M | $117.7M | |
| Revenue (Reported) | $127.5M | $133.5M | $145.4M | $147.1M | $128.5M | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $72.4M | $66.6M | $75.5M | $99M | $117.7M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $48.2M | $47.2M | $48.4M | $43.4M | $49.3M | |
| Short Term Investments | $573.8M | $439.1M | $407.7M | $481.5M | $452.3M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1B | $1.5B | $1.6B | $1.1B | $1B | |
| Property Plant And Equipment | $86.1M | $82.3M | $81.1M | $77.3M | $74.5M | |
| Long-Term Investments | $592.4M | $452.9M | $417.6M | $489.2M | $458.7M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $5.2B | $5.9B | $6.2B | $6B | $6.2B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $148.7M | $214.8M | $244.7M | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $148.7M | $214.8M | $244.7M | $122.7M | $89M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.7B | $5.3B | $5.6B | $5.4B | $5.5B | |
| Common Stock | $100.2M | $20M | $20M | $20.1M | $20.1M | |
| Other Common Equity Adj | $4.5M | $11.9M | $12.1M | -$27.2M | -$13.2M | |
| Common Equity | $538.3M | $568.2M | $601.1M | $600M | $645.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $538.3M | $568.2M | $601.1M | $600M | $645.3M | |
| Total Liabilities and Equity | $5.2B | $5.9B | $6.2B | $6B | $6.2B | |
| Cash and Short Terms | $622M | $486.3M | $456.1M | $524.9M | $501.6M | |
| Total Debt | $148.7M | $214.8M | $244.7M | -- | -- | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $47.7M | $45.5M | $46.2M | $45.9M | $49.7M | |
| Short Term Investments | $454.7M | $434.6M | $468.2M | $450.1M | $383.7M | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $1.4B | $1.6B | $1.3B | $957.4M | $906.6M | |
| Property Plant And Equipment | $81.6M | $79.1M | $77.7M | $73.6M | $71.3M | |
| Long-Term Investments | $469.8M | $445.3M | $476.3M | $456.9M | $389.3M | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $5.7B | $6.1B | $6.1B | $6.1B | $6.1B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $193.5M | $230.8M | $124.9M | $103.1M | $91.5M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $193.5M | $230.8M | $124.9M | $103.1M | $91.5M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.2B | $5.5B | $5.5B | $5.4B | $5.4B | |
| Common Stock | $100.2M | $20M | $20M | $20.1M | $20.1M | |
| Other Common Equity Adj | $11.5M | $7.3M | -$25.2M | -$31.5M | -$6.6M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $560.5M | $586.7M | $589M | $623.9M | $669M | |
| Total Liabilities and Equity | $5.7B | $6.1B | $6.1B | $6.1B | $6.1B | |
| Cash and Short Terms | $502.4M | $480M | $514.5M | $496.1M | $433.3M | |
| Total Debt | $193.5M | $230.8M | $124.9M | $103.1M | $91.5M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $57.8M | $52.5M | $61.5M | $75.2M | $58.6M | |
| Depreciation & Amoritzation | $9.9M | $10.2M | $10.6M | $10.6M | $10.8M | |
| Stock-Based Compensation | $5K | $15K | -- | -- | $103K | |
| Change in Accounts Receivable | $2.5M | -$359K | $784K | $2.5M | -$2.3M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $63.8M | $62.2M | $55.4M | $78.6M | $64.1M | |
| Capital Expenditures | $3.9M | $3.8M | $2.8M | $3.8M | $5.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$248.8M | -$35.3M | -$175.3M | -$416.6M | -$233.6M | |
| Dividends Paid (Ex Special Dividend) | -$26.4M | -$26.3M | -$26.3M | -$27M | -$27.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$35K | -$3.5M | -$2.6M | -$7M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $138.1M | $623.4M | $232.3M | -$230.9M | $96.9M | |
| Beginning Cash (CF) | $503.7M | $456.8M | $1.1B | $1.2B | $650.6M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$46.9M | $650.3M | $112.4M | -$568.9M | -$72.6M | |
| Ending Cash (CF) | $456.8M | $1.1B | $1.2B | $650.6M | $578M | |
| Levered Free Cash Flow | $59.9M | $58.3M | $52.5M | $74.8M | $58.5M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $14.1M | $16.8M | $19.4M | $14.7M | $12.9M | |
| Depreciation & Amoritzation | $2.6M | $2.6M | $2.6M | $2.7M | $2.7M | |
| Stock-Based Compensation | $4K | -- | -- | -- | $154K | |
| Change in Accounts Receivable | $166K | $438K | $775K | -$1.7M | -$1.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $19.6M | $16.4M | $22.8M | $11.9M | $16.5M | |
| Capital Expenditures | $1.4M | $594K | $584K | $815K | $929K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$59.4M | -$771K | -$81.2M | -$66.4M | -$11.7M | |
| Dividends Paid (Ex Special Dividend) | -$6.6M | -$6.6M | -$6.7M | -$6.8M | -$6.9M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $44.8M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -$1.8M | -$2.5M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $43.4M | -$5.1M | -$146.5M | -$41.6M | -$17.9M | |
| Beginning Cash (CF) | $952.8M | $1.2B | $1B | $603.4M | $536.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.5M | $10.6M | -$204.9M | -$96.1M | -$13.1M | |
| Ending Cash (CF) | $956.3M | $1.2B | $841.3M | $507.3M | $523M | |
| Levered Free Cash Flow | $18.2M | $15.8M | $22.2M | $11.1M | $15.6M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $52.5M | $59.1M | $70.6M | $69.7M | $47.4M | |
| Depreciation & Amoritzation | $10.2M | $10.5M | $10.6M | $10.6M | $11M | |
| Stock-Based Compensation | $19K | $1K | -- | -- | $566K | |
| Change in Accounts Receivable | $1.4M | -$539K | $2.8M | -$308K | $405K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $61.9M | $58.4M | $67.1M | $69.1M | $62.9M | |
| Capital Expenditures | $4.3M | $3M | $3M | $4.3M | $5.6M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$6.7M | -$171.9M | -$322M | -$305.4M | -$37.6M | |
| Dividends Paid (Ex Special Dividend) | -$26.4M | -$26.3M | -$26.7M | -$27.4M | -$27.4M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$3.5M | -$2.6M | -$5.5M | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $450.4M | $350.6M | -$97.1M | -$97.8M | -$9.6M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $505.6M | $237M | -$352.1M | -$334M | $15.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $57.7M | $55.3M | $64.1M | $64.9M | $57.3M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $38.6M | $45.3M | $54.3M | $48.8M | $37.6M | |
| Depreciation & Amoritzation | $7.6M | $7.9M | $7.9M | $8M | $8.2M | |
| Stock-Based Compensation | $14K | -- | -- | -- | $463K | |
| Change in Accounts Receivable | $390K | $210K | $2.2M | -$596K | $2.1M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $47.9M | $44.1M | $55.8M | $46.3M | $45.1M | |
| Capital Expenditures | $2.8M | $2M | $2.2M | $2.6M | $2.5M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$19M | -$155.6M | -$302.4M | -$191.1M | $4.9M | |
| Dividends Paid (Ex Special Dividend) | -$19.8M | -$19.7M | -$20.1M | -$20.5M | -$20.5M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $44.8M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$3.5M | -$2.6M | -$5.5M | -- | -$374K | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $470.6M | $197.7M | -$131.7M | $1.5M | -$105M | |
| Beginning Cash (CF) | $1.9B | $3.4B | $3.5B | $1.9B | $1.7B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $499.5M | $86.2M | -$378.2M | -$143.3M | -$55M | |
| Ending Cash (CF) | $2.4B | $3.5B | $3.2B | $1.7B | $1.7B | |
| Levered Free Cash Flow | $45.1M | $42.1M | $53.7M | $43.7M | $42.6M | |
Get TRST Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TRST
Sector
P/E ratio
13.43x
11.99x
PEG ratio
--
0.36x
P/B ratio
0.95x
1.05x
Price / LTM sales
3.73x
2.55x
Growth Metrics
TRST
Sector
Revenue growth
-6.82%
6.08%
Earnings growth
-11.69%
6.45%
Revenue (5-year growth)
1.24%
5.85%
Earnings forecast
$0.60
$0.56
Profitability
TRST
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
6.55%
5.27%
Return on assets
0.77%
0.98%
Return on equity
7.31%
9.43%
Earnings Date
Last Earnings Date
Oct
21
Next Earnings Date
Jan
22
Estimated Next Earnings Date
Jan
20
Balance Sheet
TRST
Sector
Total cash
$433.3M
$615.3M
Short term investments
$452.3M
$408.4M
Total assets
$6.2B
$4.5B
Long term debt
$91.5M
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
